These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7600121)

  • 1. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
    Padró T; Emeis JJ; Steins M; Schmid KW; Kienast J
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):893-902. PubMed ID: 7600121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the plasminogen activator system in the human vascular wall.
    Salame MY; Samani NJ; Masood I; deBono DP
    Atherosclerosis; 2000 Sep; 152(1):19-28. PubMed ID: 10996335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator expression in human atherosclerotic lesions.
    Lupu F; Heim DA; Bachmann F; Hurni M; Kakkar VV; Kruithof EK
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1444-55. PubMed ID: 7670960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.
    Kauhanen P; Sirén V; Carpén O; Vaheri A; Lepäntalo M; Lassila R
    Circulation; 1997 Sep; 96(6):1783-9. PubMed ID: 9323062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of fibrinolytic activators and inhibitors in normal and atherosclerotic vessels.
    Falkenberg M; Tjärnström J; Ortenwall P; Olausson M; Risberg B
    Thromb Haemost; 1996 Jun; 75(6):933-8. PubMed ID: 8822589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of plasminogen activators in human gingival crevicular fluid.
    Brown JM; Watanabe K; Cohen RL; Chambers DA
    Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries.
    Steins MB; Padró T; Li CX; Mesters RM; Ostermann H; Hammel D; Scheld HH; Berdel WE; Kienast J
    Atherosclerosis; 1999 Jul; 145(1):173-80. PubMed ID: 10428308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis.
    Gissler HM; Frank R; Kramer MD
    Br J Dermatol; 1993 Jun; 128(6):612-8. PubMed ID: 7687853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin.
    Padró T; Quax PH; van den Hoogen CM; Roholl P; Verheijen JH; Emeis JJ
    Arterioscler Thromb; 1994 Sep; 14(9):1459-65. PubMed ID: 8068608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants.
    Padró T; Steins M; Li CX; Mesters RM; Hammel D; Scheld HH; Kienast J
    Cardiovasc Res; 1997 Oct; 36(1):28-36. PubMed ID: 9415269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
    J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque.
    Robbie LA; Booth NA; Brown AJ; Bennett B
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):539-45. PubMed ID: 8624776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activators and their inhibitors in human saliva and salivary gland tissue.
    Virtanen OJ; Sirén V; Multanen J; Färkkilä M; Leivo I; Vaheri A; Koskiniemi M
    Eur J Oral Sci; 2006 Feb; 114(1):22-6. PubMed ID: 16460337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.
    Shireman PK; McCarthy WJ; Pearce WH; Patterson BK; Shively VP; Cipollone M; Tamarina N; Verrusio EN; Kwaan HC
    J Vasc Surg; 1996 May; 23(5):810-7; discussion 817-8. PubMed ID: 8667502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators and their inhibitor gene expression in cutaneous NF1-related neurofibromas.
    Sirén V; Peltonen J; Vaheri A
    Arch Dermatol Res; 2006 Mar; 297(9):421-4. PubMed ID: 16408192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator levels are influenced by location and varicosity in greater saphenous vein.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC; Yao JS
    J Vasc Surg; 1996 Nov; 24(5):719-24. PubMed ID: 8918314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture.
    Louwrens HD; Kwaan HC; Pearce WH; Yao JS; Verrusio E
    Eur J Vasc Endovasc Surg; 1995 Oct; 10(3):289-93. PubMed ID: 7552526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance between plasminogen activator and its inhibitors in thiol-induced acantholysis.
    Lombardi ML; de Angelis E; Rossano F; Ruocco V
    Dermatology; 1993; 186(2):118-22. PubMed ID: 8428039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
    J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.